|Mr. Timothy Paul Losik||CEO, Pres & Exec. Director||332k||N/A||1959|
|Mr. Edward Dolan||Chief Financial Officer||N/A||N/A||N/A|
|Mr. Simon Stanley||Director of Technology||N/A||N/A||N/A|
|Mr. Stephen A. Koski||Chief Information Officer||N/A||N/A||N/A|
|Mr. Fred Pilon||Head of Investor Relations||N/A||N/A||N/A|
|Mr. Stephen L. Abbey||Managing Director of Specialty Optical Fiber ("sof")||N/A||N/A||N/A|
|Mr. Jeremy Lane||Managing Director of Prophotonix UK||N/A||N/A||N/A|
|Mr. Thomas Brian Rosedale J.D.||Sec.||N/A||N/A||N/A|
ProPhotonix Limited designs, manufactures, sells, and distributes light emitting diode (LED) illumination solutions and laser modules in the United States, Canada, Mexico, South America, Europe, Asia, and internationally. The company operates through two segments, LED's (light emitting diode systems) and Laser & Diodes. It offers COBRA Cure FX series of (UV) LED curing systems for UV curing of inks, coatings, and adhesives, as well as 3D printing; and LED line light products for line scan and web inspection. The company also provides LED spot, area, and ring lights for use in machine and night vision, biomedical, life sciences, fluorescence, strobing, microscopy, security ID, and other industrial applications. In addition, it offers laser modules, including alignment, dental, industrial, medical, scientific, continuous wave, compact laser, nanosecond pulsed, photon, wavelength combiner, PROdigii digital, and structured light laser modules, as well as OEM laser modules; laser diodes and SpecBright spotlights; and UVC LED systems to kill or inactivate viral, bacterial, and fungal species. The company's products are used in 3D scanning, machine vision lighting, industrial alignment, industry solutions, defense, military, medical, UV curing, security and transport, commercial, and other industry applications. ProPhotonix Limited was founded in 1951 and is headquartered in Salem, New Hampshire.
ProPhotonix Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.